Chong Yu to Molecular Targeted Therapy
This is a "connection" page, showing publications Chong Yu has written about Molecular Targeted Therapy.
Connection Strength
0.087
-
Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan. Cancer Med. 2017 Jul; 6(7):1563-1572.
Score: 0.087
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.